Abstract:This Matters Arising article critically examines the study "Genetic susceptibility association between viral infection and colorectal cancer risk: a two-sample Mendelian randomization analysis" by Li et al., highlighting both its contributions and methodological limitations. Their study employed two-sample Mendelian randomization (MR) to explore potential causal links between viral infections and colorectal cancer (CRC), identifying significant associations with infections such as herpes simplex virus and measles. However, several aspects of the methodology warrant scrutiny, including the relaxation of instrumental variable selection thresholds, the handling of potential pleiotropy, and the interpretation of biologically implausible findings. While leveraging advanced MR techniques such as MR-RAPS, cML, ConMix, and dIVW to address challenges like pleiotropy and weak instruments, the study encountered issues related to heterogeneity, insufficient exploration of biological plausibility, and a lack of detailed reporting on instrumental variable (IV) selection and preprocessing. This Matters Arising calls for more rigorous sensitivity analyses, improved transparency in IV selection criteria and harmonization of genome-wide association study (GWAS) datasets, particularly in addressing differences between self-reported and clinically diagnosed infections. Additionally, the Matters Arising article calls for a deeper exploration of biological mechanisms, such as the role of immune modulation and inflammation, to better interpret the observed associations. By addressing these limitations, future MR studies can enhance methodological rigor, improve reproducibility, and provide more robust insights into the causal pathways linking viral infections to CRC risk.

Adding Mendelian randomization to a meta-analysis-a burgeoning opportunity

Mendelian randomization: genetic anchors for causal inference in epidemiological studies

Using Mendelian Randomization As the Cornerstone for Causal Inference in Epidemiology.

A Guide to Understanding Mendelian Randomization Studies

Use of Mendelian randomization to assess the causal status of modifiable exposures for rheumatic diseases

Application of Mendelian randomization analysis in investigating the genetic background of blood biomarkers for colorectal cancer

Mendelian Randomization Studies: Opening a New Window in the Study of Metabolic Diseases and Chronic Kidney Disease

Mendelian randomization: causal inference leveraging genetic data

Mendelian Randomization Analysis in Observational Epidemiology

Likelihood-based Mendelian randomization analysis with automated instrument selection and horizontal pleiotropic modeling

Mendelian Randomization: Concepts and Scope

Mendelian randomization in cardiometabolic disease: challenges in evaluating causality

Enhancing the robustness of Mendelian randomization studies: lessons from a two-sample analysis of viral infections and colorectal cancer

Mendelian Randomization Approach, Used for Causal Inferences

Selecting instruments for Mendelian randomization in the wake of genome-wide association studies

Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization

Benchmarking Mendelian Randomization methods for causal inference using genome-wide association study summary statistics

Mendelian randomization analysis using multiple biomarkers of an underlying common exposure

Managing the exponential growth of mendelian randomization studies

Mendelian randomization under the omnigenic architecture

Reciprocal causation mixture model for robust Mendelian randomization analysis using genome-scale summary data